Novartis runs its global website on Drupal, sharing the pharmaceutical company's research, medicines and patient resources across regional sites.
Novartis's global website runs on Drupal with a custom build. It communicates the pharmaceutical company's research and development, its medicines and therapeutic areas, resources for patients and healthcare professionals, and corporate and sustainability news. Operating in a heavily regulated industry, the site must manage carefully controlled content across multiple regional and country sites while meeting compliance and accessibility standards. Novartis illustrates how Drupal serves large life-sciences organisations that need structured, governable content delivered reliably to distinct audiences around the world.
